E-mail Us

A Noteworthy Contender: Blood Glucose Meter Accuracy Exceeds Industry Standard

In the quest for effective diabetes management, accurate blood glucose monitoring stands as a cornerstone. Last time, we talked about the core Haematocrit Correction Technology applied in TeleRPM BGM Gen 1, which help enhance the accuracy to a higher level. The accuracy complies with the standard ISO15197:2013 / 2015, and the clinical test report is conducted by German IDK, a well-known blood glucose meter test agency, therefore the result is proved to be accurate. But what’s the accuracy exactly lies in, let’s discover more details of the accuracy this time.

Accuracy that Exceeds the Standard ISO15197:2013 / 2015

The continuous advancement of medical technology has led to remarkable progress in this field, with blood glucose meters playing a pivotal role in empowering individuals to take control of their health. Accurate blood glucose readings are the foundation of effective diabetes management. In the industry, the standard ISO15197:2013 / 2015 requires that 95% of the clinical results fall within ± 15%, 98.8% of the results of TeleRPM BGM Gen 1 fall within an impressive ± 15% range, which means the accuracy is ahead of the standard. With the reliable accuracy that TeleRPM BGM Gen 1 offers, individuals with diabetes can confidently make informed decisions about their diet, medication, and overall lifestyle.


How Does the Results 98.8% Come from?

The data and results are from the independent evaluation report of IDK in Germany. 200 people in each group were tested and compared, and the final test data of 600 people were obtained.


Accuracy Stands Shoulder-to-shoulder with Roche

The measure of a truly exceptional blood glucose meter is its ability to stand shoulder-to-shoulder with established giants in the field. In this realm, the latest TeleRPM BGM Gen 1 takes center stage, positioning itself at the same level as the esteemed Roche brand. Roche, a recognized leader in healthcare diagnostics, has set a high standard for accuracy and reliability. This time TeleRPM BGM Gen 1 is in the same level as Roche shows its potential to reshape the diabetes monitoring landscape.


The accuracy of TeleRPM BGM Gen 1 is inspiring, with years of deep dive and innovation in the medical device industry, Transtek TeleRPM holds the promise of further breakthroughs in diabetes management. With continued research, development, and innovation, we can anticipate even more advanced blood glucose meters that push the boundaries of accuracy, making diabetes care more personalized, efficient, and effective.

Related TRANSTEK Products

Zone A No.105 Dongli Road Torch Development District, Zhongshan City, Guangdong Province, China
+86-0760-88282982 / 85166220